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10 Abstract
11 The increasing number of mastectomies results in a greater demand for breast reconstruction characterized by simplicity and
12 aQ1 low complication profile. Reconstructive surgeons are investigating tissue engineering (TE) strategies to overcome the
13 current surgical drawbacks. 3D bioprinting is the rising technique for the fabrication of large tissue constructs which
14 provides a potential solution for unmet clinical needs in breast reconstruction building on decades of experience in
15 autologous fat grafting, adipose-derived mesenchymal stem cell (ASC) biology and TE. A scaffold was bioprinted using
16 encapsulated ASC spheroids in methacrylated gelatin ink (GelMA). Uniform ASC spheroids with an ideal geometry and
17 diameter for bioprinting were formed, using a high-throughput non-adhesive agarose microwell system. ASC spheroids in
18 adipogenic differentiation medium (ADM) were evaluated through live/dead staining, histology (HE, Oil Red O), TEM and
19 RT-qPCR. Viable spheroids were obtained for up to 14 days post-printing and showed multilocular microvacuoles and
20 successful differentiation toward mature adipocytes shown by gene expression analysis. Moreover, spheroids were able to
21 assemble at random in GelMA, creating a macrotissue. Combining the advantage of microtissues to self-assemble and the
22 controlled organization by bioprintingQ2 technologies, these ASC spheroids can be useful as building blocks for the
23 engineering of soft tissue implants.
24 1 Introduction
25 Breast cancer is the most common cancer in women
26 worldwide, with nearly 1.7 million new cases diagnosed in
27 2012 (second most common cancer overall). This represents
28 about 12% of all new cancer cases and 25% of all cancers in
29 women [1]. Mastectomies impair the esthetic appearance,
30 function and psychological well-being of patients. In
31addition to breast reconstruction following mastectomy for
32established breast cancer, an increasing number of women
33with BRCA mutations (25%) is opting for prophylactic
34mastectomy followed by breast reconstruction, indicating
35the need for soft tissue implants [2]. The success of con-
36ventional implant-based breast reconstruction has been
37hindered by complications such as capsular contracture,
38infection, rupture, foreign body reaction and anaplastic
39large-cell lymphoma [3]. Adipose tissue (AT), in the form
40of a free flap, has been the preferred method of choice since
41patients are pleased with the natural shape, consistency and
42permanency of the superior esthetic results [4]. Despite
43major advancements in microsurgery and transplantation,
44reconstruction remains hindered by the availability of donor
45sites. Even in less extensive cases, the harvest of donor
46tissue carries a significant risk of donor site morbidity and
47the potential for failure, infection, and degradation at the
48host site. The microvascular nature of the surgical procedure
49makes it a costly solution and requires a high level of sur-
50gical skill [5]. Surgeons are persistently attempting to
51optimize surgical techniques and investigating new
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52 technologies regarding soft tissue deformities due to high
53 patient expectations for improved functional/cosmetic out-
54 comes [6]. Tissue engineering (TE) strategies are widely
55 investigated to overcome the current surgical drawbacks.
56 3D bioprinting is a promising and popular branch of
57 modular TE. 3D bioprinting has garnered immense interest
58 over the last decade. The goal of bioprinting is to replace
59 damaged tissues with live, vascularized, de novo created
60 biosimilar constructs, suitable for surgical implantation. It
61 promises to bridge the gap between artificially engineered
62 tissue constructs and native tissues since it can co-deliver
63 cells and biomaterials with precise control over the com-
64 position, spatial distribution, and architectural accuracy [7].
65 Computer software is able to extract data from patient
66 images such as computed tomography scans or magnetic
67 resonance imaging to produce tailor-made tissue implants.
68 3D culture models have been cited to overcome the gap
69 between in vitro and animal studies in early-stage drug
70 screening. In preclinical setting 95% of oncology drugs fail
71 to receive FDA approval [8]. Part of the issue can be
72 administered to the lack of suitable culture models that
73 represent the in vivo environment. 3D culture models such
74 as spheroids have proven to exhibit much more in vivo-like
75 phenotype concerning cell metabolism and cell-cell inter-
76 action compared to any planar cell culture [9].
77 Spheroids or microtissues are cellular building blocks for
78 fabricating a construct with a cellular organization. They
79 can be compared to organoid structures encountered in
80 embryology [10]. The organization of cells into a spheroid,
81 or the fusion of spheroids into a macrotissue, is explained
82 by the differential adhesion hypothesis (DAH). The DAH
83 states that multicellular spheroids behave like liquids.
84 Spheroids, consisting of motile cells, will rearrange and
85 merge to maximize their adhesive bonds and minimize their
86 free energy [11]. They can be stacked in a 3D composition
87 to form larger constructs [12]. Experiments with tissue
88 spheroids show that closely placed spheroids will fuse into
89 larger microtissues [13]. This has been demonstrated by
90 Jakab et al. [14], who placed two rounded embryonic heart
91 cushion tissue explants in a hanging drop culture. These
92 spheroids fused perfectly by fusion kinetics described for
93 the fusion of two droplets [15]. Benefits of 3D spheroids
94 over 2D monolayer cultures include increased adipogenic
95 markers such as triglyceride accumulation as well as
96 expression of adipose-specific genes such as peroxisome
97 proliferator-activated-receptor-γ (PPAR-γ) [16]. Turner
98 et al. [17] created a 3D spheroid model using human
99 adipose-derived mesenchymal stem cells (ASCs) and their
100 subsequent adipogenic differentiation in vitro. Mature ASC
101 spheroids were evaluated based on functional markers such
102 as CD36-expression and PPAR-γ gene expression. The
103 authors report minimal spheroid loss during culture. The
104 CD36-expression, representing cell competency for
105consuming extracellular fatty acids, was consistently found
106to be higher in 3D ASC spheroids compared to 2D mono-
107layers. Such head-to-head comparison of 3D cultures vs 2D
108monolayer cultures may lead to a better in vitro model to
109uncover important biological mechanisms involved in dis-
110eases such as obesity and marks the importance of a 3D
111culture model in preclinical setting.
1123D spheroids have been found to enhance pluripotent
113potential and differential efficacy of multiple mesenchymal
114cell lines when exposed to appropriate differentiation media
115in vitro [17, 18]. Kapur et al. [19] explored growth, com-
116position and behavior of culture-expanded ASC spheroids
117using hanging-drop method. Their study demonstrates that
118ASC spheroids display a capacity for extensive renewal,
119developmental plasticity and internally directed organiza-
120tion. Their work confirms that ASC spheroids may be used
121to provide a flexible and practical modular foundation to
122build tissues and organs using bioprinting techniques.
123Bioprinting relies on the use of a hydrogel as a cell-
124supporting matrix [20]. Hydrogels have become an attrac-
125tive scaffold for TE purposes due to their ability to closely
126mimic the native tissue extracellular matrix (ECM) [6].
127Various cell types such as adult cells, human umbilical vein
128endothelial cells (HUVECs), fibroblasts, cardiomyocytes,
129myoblasts, mesenchymal stem cells (MSCs), bone marrow-
130derived mesenchymal stem cells (BM-MSCs), neural stem
131cells (NSCs), ASCs, human induced pluripotent stem cells
132(iPSCs), glioma stem cells, and amniotic fluid-derived stem
133cells have been used for 3D bioprinting [21]. Despite good
134proofs of concept of appropriate matrices for bioprinting
135[22–24], the technology is still in its infancy and bioinks
136only recently became commercially available. Biomaterials
137such as alginate, fibrin, hyaluronic acid, silk, chitosan,
138decellularized ECM and pluronic F-127 have been used as
139scaffold material [25]. Collagen is one of the most abundant
140proteins present in the human body (around 30%) [26]. Yao
141et al. [27] encapsulated ASCs in collagen/alginate micro-
142spheres and after 4 weeks of culture, the spheres were
143macroscopically similar to AT lobules. After injection in
144mice, the authors observed vascularized AT constructs. It
145remains difficult to reproduce the delicate structure-function
146relationships of complex tissues and organs using this
147approach.
148Van Vlierberghe et al. [28] noted that the desired scaffold
149for TE should have the modifiable mechanical properties of
150synthetic biomaterials and the biomimetic properties of
151naturally occurring biomaterials. Gelatin, a biopolymer
152formed by the hydrolysis of collagen, and its derivatives are
153some of the nature-derived bioinks that have gained sig-
154nificant attention. Generally, they have good biocompat-
155ibility, are cell supportive, biodegradable and easily
156optimized for bioprinting [25]. Vashi et al. [26] reported
157successful adipogenesis in mice after implanting a TE
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158 chamber filled with gelatin microspheres impregnated with
159 bFGF-2. An important limitation of natural biomaterials is
160 their rapid rate of degradation upon contact with bodily
161 fluids or culture media [29]. At low temperatures, gelatin
162 forms a physical hydrogel network. In order to circumvent
163 dissolution at 37 °C, methacrylamide-groups are incorpo-
164 rated into the gelatin. Gelatin-Methacrylamide (GelMA) is
165 usually crosslinked with photoinitiators that allow to retain
166 its biocompatibility with minimal cytotoxicity [30]. Long-
167 term stability of the printed structure typically depends on
168 the crosslinking mechanism after or during bioprinting.
169 Irgacure® 2959 (Irg) is widely considered the golden stan-
170 dard for GelMA hydrogel crosslinking. Free radicals are
171 created by the interaction of the photoinitiators with visible
172 or UV light and initiate the polymerization reaction. This
173 results in the formation of a stable chemically crosslinked
174 gelatin network at physiological conditions after physical
175 and chemical crosslinking [31]. GelMA is a cheap and easy
176 to handle shear thinning biomaterial, which makes it sui-
177 table for extrusion-based printing methods. GelMA presents
178 both natural cell binding motifs, such as RGD (Arg-Gly-
179 Asp) and MMP-sensitive degradation sites, and different
180 amino acid side-chain functionalities (carboxylic acid,
181 amines, hydroxyl) which allow for further covalent mod-
182 ifications such as with hyaluronic acid [32]. Clevenger et al.
183 [33] encapsulated ASCs in a biomimetic poly(ethylene)
184 glycol (PEG) hydrogel with RGD cell attachment sequences
185 along with MMP cleavage sites. ASC survival was sup-
186 ported, and the hydrogel demonstrated scaffold remodeling
187 upon ASC differentiation, which potentially allows for
188 greater vascularization of the graft through the holes created
189 in the hydrogel scaffold through MMP cleavage. Huber
190 et al. [34] encapsulated mature adipocytes in GelMA and
191 was able to produce fatty tissue equivalents reaching similar
192 tissue morphology to that of native fatty tissue after 14 days
193 of culture. The authors proved that GelMA is a promising
194 bioink for new printing techniques due to its biocompat-
195 ibility and tunable properties.
196 The aim of the present work is to successfully fabricate
197 high throughput adipogenic differentiated ASC spheroids
198 and subsequently bioprint the ASC spheroids encapsulated
199 in GelMA into a 3D construct for adipose tissue engineering
200 (ATE). First, adipogenic differentiation of ASC spheroids
201 was compared to a 2D culture. Second, ASCs and ASC
202 spheroids were seeded on or encapsulated in GelMA.
203 Finally, the encapsulated ASCs and ASC spheroids were
204 3D bioprinted. 3D bioprinting technology provides a
205 potential solution for unmet clinical needs in breast recon-
206 struction that builds on decades of experience and expertise
207 in autologous fat grafting, ASC biology and TE. No studies,
208 till now, have considered the use of bioprinting technology
209 to fabricate AT constructs using predifferentiated ASC
210 spheroids. The development of successful printing
211strategies requires investigation of all key elements in this
212process.
2132 Materials and methods
2142.1 Adipose-derived mesenchymal stem cell culture
215ASCs (Cryo-Save, Niel, Belgium), characterized as CD105+,
216CD90+, CD73+, CD45−, CD34− (according to the Inter-
217national Federation for Adipose Therapeutics and the
218International Society for Cellular Therapy) by flow cyto-
219metry [35], were cultured in standard culture medium
220(SCM) consisting of Dulbecco’s modified eagle’s medium
221(DMEM) Glutamax (Gibco®, Life Technologies), supple-
222mented with 10% fetal bovine serum (FBS) (Gibco®, Life
223Technologies), and 1% Penicillin/Streptomycin (Gibco®,
224Life Technologies) in T75 (75 cm2) CELLSTAR™ Filter
225Cap Cell Culture Flasks (Greiner Bio-One GmbH,
226Germany, Cat. No. 82050-856) at a density of
227350,000–500,000 cells per falcon as previously described
228[35, 36]. The falcons were placed and maintained in a
229humidified 5% CO2-containing atmosphere at 37 °C. Cul-
230ture medium was replenished twice a week. Once 80–90%
231confluency was achieved, ASCs were dissociated from the
232culture flasks with TrypLE® (Gibco®, Life Technologies).
233Adipogenic differentiation medium (ADM) consists of
234SCM supplemented with 1 μM dexamethasone (Sigma-
235Aldrich®, D4902), 200 μM indomethacin (Sigma-Aldrich®,
236I7378), 10 μg/mL insulin (Sigma-Aldrich®, I9278), 0.5 mM
2373-isobutyl-1-methylxantine (IBMX) (Sigma-Aldrich®,
238I5879). All cell types were used up to passage 10 and were
239cultured at 37 °C in a humidified 5% CO2-containing
240atmosphere.
2412.2 Microchip fabrication, spheroid formation and
242collection
243Spheroids were generated by using a non-adherent micro-
244well culture system, as previously described [37, 38]. Tai-
245lor-made, negative polydimethylsiloxane (PDMS)
246microchip molds have a diameter of 1.8 cm and generate a
247microchip with 2865 pores with a diameter of 200 μm
248consisting of Ultrapure™Agarose (Life Technologies) 3w/v%.
249In total, 106 ASCs in 0.5 mL SCM were seeded per
250microchip to obtain spheroids [39]. After 24 h, SCM was
251removed and replenished with ADM. The morphology of
252the spheroids was analyzed through observation utilizing
253phase-contrast microscopy (Olympus IX 81). The evalua-
254tion of the morphometry was performed using the Xcel-
255lence image software that allowed the determination of
256several parameters, such as diameter, perimeter (p), and
257area (A).
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258 The formula fcircularity= (4πA)/p2 enabled the ability to
259 calculate the circularity of the spheroids. For diameter and
260 circularity evaluation, phase-contrast images of 75 spher-
261 oids cultured in SCM or ADM (illustrated in Fig. 1),
262 derived from three independent experiments (n= 3), were
263 assessed at 1, 4, 8 and 13 days. Spheroids were harvested at
264 1, 4, 8 and 13 days from the microchips in their respective
265 medium, collected in a tube, and centrifuged to obtain a
266 spheroid pellet and further analyzed with phase contrast
267 microscopy, fluorescence microscopy, histology and q-RT-
268 PCR as described below. For 3D hydrogel and bioprinting
269 experiments, spheroids were collected after 3 days and
270 encapsulated in GelMA subsequently.
271 2.3 2D GelMA hydrogel evaluation
272 2.3.1 2D adipogenic differentiation on GelMA hydrogels
273 GelMA, provided by the Polymer Chemistry and Bioma-
274 terials group (UGent), with a degree of substitution of 95%
275 (DS95) was sterilized with ethylene oxide (cold cycle, AZ
276 Sint-Jan, Brugge) and dissolved in PBS at 37 °C to obtain a
277 10 w/v% solution. 1-[4-(2-Hydroxyethoxy)-phenyl]-2-
278 hydroxy-2-methyl-1-propane-1-one, also known as Irg
279 (Ciba® Specialty Chemicals, Basel, Switzerland), was made
280 to a concentration of 0.8 w/v% in PBS and mixed with
281 GelMA according to the formula below.
The amount inmLð Þ of Irg 2mol%ð Þ needed for one gram of GelMA ¼
0:000385 mole amine functions for 1g of GelMAð Þ  0:95
DS%ð Þ  0:02 2mol% Irgacure 2959ð Þ
224:3 Molecular weight of Irgacure 2959ð Þ
0:008 0:8wv% concentration of Irgacure 2959ð Þ
2823
284 Hydrogel discs were prepared by pipetting 250 μl
285 GelMA solution in each well of a 48-well plate and
286crosslinked for 20 min with 365 nm UV-A light (4 mW/cm²,
287UVP Inc.) in the presence of 2 mol% Irg.
288In total, 20,000 ASCs in 0.5 mL SCM were seeded on
28948-Multiwell Plates (21,053 ASCs/cm2) containing the
290hydrogels. As control, ASCs were seeded with a density of
29140,000 cells/well in 24-well plates (21,053 ASCs/cm2).
292After 48 h, SCM or ADM was added to the wells. Differ-
293entiation was observed at day 7, 11 and 14. ASCs were
294analyzed with fluorescence microcopy and q-RT-PCR as
295described below.
2962.3.2 Encapsulation of ASCs and spheroids in GelMA
297GelMA DS95 was prepared and mixed with Irg as described
298in “2D adipogenic differentiation on GelMA hydrogels”.
299ASCs were resuspended in the GelMA/Irg-solution at a
300concentration of 106 ASCs 250 μL−1. Spheroids were sus-
301pended in the GelMA/Irg-solution at a concentration of 1
302microchip (106 ASCs) 250 μL−1. The 250 μL-suspensions
303were added to 48 multiwell plates. After physical gelation
304of 30 min at 4 °C, the solution was illuminated for 15 min
305with UV-A (365 nm, 8 mW cm−2, UVP Inc.) in a laminar
306flow cabinet with a TFL-40V transilluminator (UVP
30795042001, Thermo Fisher Scientific Inc.). Constructs were
308cultured in ADM. Analyses were conducted on day 7, 11,
30914 and 23.
3102.4 Bioprinting
3113D bioprinting was performed with the 3DDiscovery®
312(RegenHU LTD) using a time pressure-based printhead.
313Printing parameters such as printing pressure, printing
314temperature, needle geometry and diameter, feedrate, as
315well as the mechanical properties of the bioink will influ-
316ence the thickness of the strands. 3D models can be
Figure 1 Phase contrast images (×10) of spheroids cultured in SCM (a–d) and spheroids cultured in ADM (e, f) on day 1, 4, 8 and 13
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317 designed layer-by-layer with BioCADTM, a drawing suite
318 enabling us to design a scaffold from scratch (as seen in
319 Fig. 2). The BioCAMTM software then generates a toolpath
320 based on the 3D digital models acquired from the Bio-
321 CADTM software.
322 ASCs and spheroids were encapsulated in GelMA at a
323 concentration of respectively 4 × 106 cells mL−1 and 4
324 microchips mL−1. The single cell or spheroid-laden GelMA
325 is placed in the cartridge heater (23 °C). Four layers were
326 printed (Fig. 2). Each layer consists of ten struts. A conical
327 needle with gauge 25 (ID of 0.25 mm) was used to print,
328 which resulted in constructs with a height of ±1 mm. The
329 constructs are made of layers with dimensions of 13 ×
330 13 mm and a line space of 1 mm.
331 After printing at 5 mm s−1, the constructs undergo phy-
332 sical gelation (30 min at 4 °C) before being crosslinked
333 under the same conditions as previously mentioned. To
334 intensify cross-linking, immersion fluid, consisting of PBS
335 with photoinitiator in equal concentration as the GelMA-
336 solution, was added. After crosslinking, the structures are
337 rinsed with PBS and submerged in appropriate medium and
338 placed in an incubator at 37 °C and 5% CO2.
339 2.5 Analyses and assays
340 2.5.1 Live/dead assay
341 A live/dead viability assay was conducted with Calcein AM
342 (CA) (cell-permeant dye, Anaspec, AS-89201) and propidium
343 iodide (PI) (Sigma-Aldrich®, P4170) to measure the viability
344 of ASCs and spheroids. Pictures were made using an inverted
345 fluorescence microscope (Olympus IX 81) with filters for
346 green fluorescent protein (GFP) and Texas Red (TxRed). The
347 microscope is equipped with Xcellence software (Olympus).
348Confocal images were captured with a Nikon A1R
349inverted confocal microscope with a dry objective (×10)
350and NIS Elements Viewer software (Nikon Instruments
351B.V.). EGFP laser (488 nm) and TxRed laser (561 nm) were
352selected. ND2-files were imported in (Fiji is just) Image J
353for analysis.
3542.5.2 Oil Red O
355Oil Red O staining was performed on 2D differentiation and
356spheroid experiments. ASCs or spheroids were rinsed with
357PBS and fixed with 4% NBF (neutral buffered for-
358maldehyde). After rinsing with distilled water, dehydrating
359with 60% Isopropanol and staining with Oil Red O, the cells
360could be visualized with light microscopy (Olympus IX 81).
3612.5.3 Hematoxylin–eosin staining
362Spheroids were fixed with 4% NBF overnight after 14 days
363of culture. The spheroids were passed through decreasing
364alcohol concentrations (100, 90, 80, 70%) and embedded in
365paraffin to obtain 5 μm coupes with a microtome. The
366sections were colored with HE and evaluated with light
367microscopy (Olympus BX51).
3682.5.4 OsO4 staining and transmission electron microscopy
369Spheroids were fixed with 2% glutaraldehyde after 14 days
370of culture. Glutaraldehyde was replaced with cacodylate
371buffer after 1 h. The buffer was replaced by osmiumtetra-
372oxide for 90 min and again replaced by cacodylate buffer.
373Afterwards, increasing acetone concentrations were added
374to the spheroids to be finally embedded in Spurr kit
375(Sigma). Semi-thin sections of 1 μm were mounted,
Figure 2 BioCADTM software
3D image of the design.
Scaffolds with ten struts and
four layers in six-well plates
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376 counterstained with hematoxylin–eosin and analyzed with
377 light microscopy.
378 Thin sections (60 nm) were cut, stained with uranyl
379 acetate and lead citrate and examined using a JEOL 1200
380 EX II transmission electron microscope operating at 80 keV
381 [36, 40].
382 2.5.5 Gene expression analysis (RT-qPCR)
383 To evaluate adipogenic differentiation, TaqMan gene
384 expression assays (Applied Biosystems, Foster City, Cali-
385 fornia) were performed for PPAR-γ and fatty acid binding
386 protein 4 (FABP-4) on day 7 after encapsulating spheroids
387 or bioprinting. PPAR-γ is a member of the nuclear-receptor
388 superfamily and a regulator of adipocyte differentiation
389 [41]. FABP-4 is a late marker of differentiation, encoding
390 the fatty acid binding protein found in adipocytes, and its
391 roles are believed to include fatty acid uptake, transport, and
392 metabolism [42]. Total RNA was extracted from cells
393 using Trizol (Qiagen, Vento, The Netherlands), and trea-
394 ted with DNAse I (Invitrogen). Concentration and purity
395 of RNA was measured using spectrophotometry, after
396 which reverse transcriptase reaction was performed using
397 a universal reverse transcriptase kit (Eurogentec, Liege,
398 Belgium) according to the company’s protocol. Reverse
399 transcriptase–quantitative polymerase chain reaction was
400 performed for gene expression analysis on the 7500 Fast
401 Real Time Polymerase Chain Reaction System (Applied
402 Biosystems, Foster City, Calif.). Relative quantification
403 (n-fold expression) values were calculated using the
404 equation 2−ΔΔCt relative to control ASCs at day 0.
405 GAPDH (4326317E-0906030) was selected as endogen-
406 ous control.
407 2.5.6 Confocal images and Image J
408 To investigate the impact of 3D bioprinting on viability,
409 scaffolds containing encapsulated spheroids were compared
410 with 3D bioprinted spheroid scaffolds (n= 30) through
411 confocal images (Nikon A1R inverted confocal microscope)
412 after 7 days of culture in ADM. Spheroids were fabricated
413 and encapsulated in GelMA as stated above. Scaffolds were
414 3D bioprinted under the same conditions as stated in 3.4.
415 CA/PI was added to the encapsulated spheroids and printed
416 scaffolds and incubated for 30 min. Confocal images were
417 taken by a Nikon A1R inverted confocal microscope with
418 NIS Elements AR software. 10 μm coupes were taken at
419 random points to give a full image-depth at a certain point.
420 The ND2-files were imported in (Fiji is just) Image J software.
421 Viability was measured according to standard protocol by
422 Bioactive Regenerative Therapeutics, Inc. Channels were split
423 in red and green channels, converted to 8-bit and projected in
424 one focal plane. Intensities were measured and quantified.
4252.6 Statistics
426All analyses represent data from three independent experi-
427ments. Data were analyzed using SPSS version 24.0 (SPSS
428GmbH Software) and are presented in the form of mean ±
429SD. To test for normality of the variables, the Shapiro–Wilk
430test was performed. The homogeneity of variances was
431assessed using the Levene’s test. A student’s t test was used
432to determine significant differences in sphericity and dia-
433meter between spheroids cultured in ADM and spheroids
434cultured in SCM on day 1, 4, 8 and 13. The difference in
435mean survival after 7 days of culture of spheroids encap-
436sulated in GelMA vs spheroids bioprinted after encapsula-
437tion in GelMA was determined using a student’s t test. To
438indicate the equivalent differentiation rates in both study
439groups, tested with the differentiation assay, a
440Mann–Whitney U test was performed. Statistical sig-
441nificance was considered to be a p value less than 0.05.
4423 Results
4433.1 Biofabrication of adipose-derived mesenchymal
444stem cell spheroids
445Spheroids were formed by seeding 1,000,000 ASCs on each
446agarose microchip with 200 μm pores in presence of SCM.
447Each agarose microchip has 2865 pores of 200 μm diameter,
448thus one microwell contains ~349 cells which will form one
449spheroid. Within 24 h after seeding, the ASCs formed
450spheroids and SCM was replenished with ADM (Fig. 1e) and
451compared to spheroids cultured in SCM (Fig. 1a) for 13 days.
452Spheroid geometry was characterized by measuring the
453diameter and circularity. Evaluation of the diameter of the
454spheroids cultured in SCM after 1, 4, 8 and 13 days showed
455significant smaller spheroids compared to spheroids cul-
456tured in ADM over time. The spheroids cultured in SCM
457decreased from a diameter of 134 ± 9.92 μm on day 1 to a
458diameter of 68 ± 4.63 μm on day 13. Spheroids cultured in
459ADM also decreased over time, albeit less significantly than
460the SCM group. On day 1 the average diameter was 153 ±
4619.18 μm and decreased to 101 ± 5.70 μm on day 13. Both
462groups showed compaction during the entire experiment but
463more pronounced in the SCM group (Fig. 1e). After 8 days,
464the diameter is maintained in both groups (Fig. 3). Spher-
465oids cultured in SCM were less uniform, smaller, more
466polygonal in shape and prone to disintegrate over time,
467associated with a higher amount of cell debris (Fig. 1d).
468Spheroids cultured in ADM have a significantly larger
469diameter (p < 0.001 with Student’s t comparison) compared
470to spheroids cultured in control medium on day 1 (19.16 μm
471CI: [13.75; 24.58]), 4 (45.5 μm CI: [41.9; 49.0]), 8 (30.5 μm
472CI: [28.2; 32.9]) and 13 (32.8 μm CI: [29.8; 35.7]).
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476 measuring the circularity, which is calculated by the for-
477 mula 4 π Area
Perimeter2
. A value of 1 indicates a perfect circle.
478 Spheroids cultured in ADM are significantly more circular
479 (p < 0.001 with Student’s t comparison) at day 4 (11.1% CI:
480 [0.089; 0.134]), 8 (17.3% CI: [0.143; 0.203]) and 13 (30.8%
481 CI: [0.274; 0.342]). Circularity remained stable >90% in the
482 ADM group. Circularity slightly increased from day 1 to
483 day 13 for the adipogenic differentiation group, correlating
484 with the decrease in diameter and showing compactness.
485 The morphology and differentiation capacity of ASC
486 spheroids was analyzed with different methods: Oil Red O,
487 HE, OsO4 (light microscopy and electron microscopy) as
488 seen in Figs. 4 and 5. Oil Red O staining showed a more
489 intense and uniform staining of lipid droplets compared to
490 control. HE staining of spheroids in adipogenic culture
491 medium showed cavities that might indicate lipid droplets
492 since lipids dissolved in alcohol upon staining (Fig. 4, HE,
493 black arrow). This is in contrast to spheroids in SCM which
494 showed no cavities. Upon fixation with glutaraldehyde and
495 OsO4 on day 13, intracellular lipid droplets were visualized
496 in spheroids cultured in ADM. Spheroids cultured in SCM
497 showed minuscule lipid droplets, indicating less differ-
498 entiation. Electron microscopy analysis (Fig. 5) confirmed
499 the presence of giant lipid droplets and collagen III (one of
500 the main constituents of the interstitial matrix, secreted by
501 adipogenically differentiated cells) deposition in spheroids
502 cultured in ADM.
5033.2 Compatibility of single cells with GelMA
504Single cells seeded on GelMA hydrogels (Fig. 6a) showed
505good viability in both the adipose group and the control
506group. Up to 14 days after seeding the ASCs on GelMA, a
507high viability was seen. The ASCs cultured in adipogenic
508differentiation medium showed a polyhedral morphology
509with multiple vacuoles. Cells in SCM expressed a more
510fibroblast-like morphology with minimal differentiation.
511This form was maintained with minimal increase of min-
512uscule lipid droplets by day 14. Upon Oil Red O staining,
513differentiation was significantly higher compared to con-
514trols, which retained a spindle shape. A multivacuolar
515morphology, filling the cytoplasm, was seen after 14 days of
516culturing. In the control groups, almost no Oil Red O
517staining could be seen.
518After 14 days, vacuoles with lipids could be observed in
519encapsulated single cells in GelMA (Fig. 6, g). Even after
52014 days we had perfect viability in the adipose group, in
521which the adipocytes showed a typical polyhedral mor-
522phology. Since cells are embedded in 3D, the micro-
523environment is more related to natural AT. Up to 23 days
524after encapsulating the ASCs in GelMA, a high viability
525was seen.
5263.3 3D printing of ASCs/spheroids encapsulated in
527GelMA
528Constructs were 3D printed with a time-pressure printhead
529(DD-135N) at RT (19 °C) with a cartridge heater
Figure 3 Sphericity and diameter of spheroids cultured in ADM or
SCM at 1, 4, 8 and 13 days. Spheroids cultured in ADM are sig-
nificantly more circular and have a larger diameter compared to
spheroids cultured in control medium at each day (p < 0.001, with
Student’s t comparison). Bar graphs represent standard deviation
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530 (CF-300H) set to 23 °C. The 3DDiscovery© was set to a
531 feedrate setting (5 mm s−1). Printing took around 15 min to
532 complete a six-well plate with squared scaffolds of 13 and
5331 mm high (Fig. 7). After physical gelation at 4 °C for
53430 min, the constructs were illuminated under UV light
535(365 nm) at 8 mW cm−2 for 15 min in immersion fluid, to
Figure 4 Viability analysis with
Ca/PI and differentiation
analysis with Oil Red O, HE,
OsO4 fixation (light
microscopy, HE) after 7 days.
Spheroids were cultured in SCM
or ADM. Ca/PI staining was
analyzed with fluorescence
microscopy, differentiation was
analyzed with light microscopy.
White arrow: amorphous zone.
Black arrow: lipid droplet
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536 counter dissolution of the scaffolds at 37 °C due to ineffi-
537 cient crosslinking of GelMA. After photocrosslinking, the
538 immersion fluid was removed, the constructs were rinsed
539 with PBS and ADM or SCM (control) was added. The
540 constructs were incubated at 37 °C and 5% CO2.
541 In total, 95% of the scaffolds were intact after 24 h at
542 37 °C. Viability was good in both the adipose group as in
543 the control groups (Fig. 7). As seen in all pictures, a
544 homogenous distribution of cells was obtained. Equal via-
545 bility was observed at the edges of struts as at the center of
546 struts. Almost no dead cells were observed after 7 days of
547 culture. In the spheroid group, a heterogeneous solution for
548 printing was obtained. Spheroids were homogeneously
549 distributed in the GelMA bioink as well as in the printed
550 GelMA scaffold. Typical adipocyte features such as uni-
551 vacuolar morphology, or a gridQ3 structure cannot be
552 observed within 7 days of culture (Fig. 8).
553 No significant difference was found in viability between
554 spheroids encapsulated in GelMA (80% ± 0.086) and
555 spheroids encapsulated in GelMA and subsequently bio-
556 printed (79% ± 0.078) after 7 days of culture (p > 0.05 and
557 n= 30). Obtained images through CLSM are illustrated in
558 Fig. 9.
559 In TE, microtissues are used as building blocks for the
560 assembly of larger tissue constructs. Giant cell clusters were
561 noticed in the gel 7 days post-printing the scaffolds (Fig. 9).
562 3.4 RT-qPCR
563 To assess adipogenic differentiation, upregulation of key
564 adipogenic marker genes was detected at transcriptional
565 level (Fig. 10). PPAR-γ and FABP-4 mRNA levels were
566 quantified after 7 days of culture in ADM using RT-qPCR.
567 As negative control sample, ASCs cultured in standard
568 culture medium for 7 days, was used for comparison. An
569 upregulation of the adipogenic specific genes was observed
570 in spheroids cultured in microchips in ADM (Sphe),
571 spheroids encapsulated in GelMA and cultured in ADM
572(GM Sphe) and spheroids encapsulated in GelMA and
573subsequently bioprinted (Print Sphe). mRNA levels of
574FABP-4 were five times higher and PPAR-γ levels were
575twice as high compared to the control sample. No sig-
576nificant difference in gene expression was found when
577comparing the different spheroid conditions. A clear trend
578in upregulation of both genes is seen in all spheroid con-
579ditions compared to positive control consisting of ASCs
580cultured in adipogenic culture medium for 7 days.
5814 Discussion
582Classic top down TE approaches originate from attempts by
583chemical engineers to create porous scaffolds from biode-
584gradable polymers as a temporary template that supports
585cell attachment and tissue neomorphogenesis [43]. This
586approach is hindered by limited control over cell–cell
587contact and microarchitecture [44]. In the context of mod-
588ular bottom-up TE, spheroids are used as micro-building
589blocks for the fabrication of a macrotissue. In the present
590study, we developed a method to bioprint viable ASC
591spheroids, encapsulated in GelMA, in a desired 3D con-
592figuration. The use of a 3D bioprinter enables us to
593assemble these building blocks layer-by-layer with high
594spatial control.
595ASCs have become the focus in many TE strategies. The
596abundantly availability of AT and its inherent regenerative
597potential allows patients to donate a sufficient quantity for
598cell isolation with minimal risk of adverse effects. They are
599abundantly available, easy to harvest, multipotent and less
600painful to extract than BM-MSCs. They can easily be
601extracted after small liposuction under local anesthesia. AT
602possesses superior stem cell content compared to other
603tissues; as much as 2% of the cellular content of adipose
604may be ASCs, compared to 0.002% BM-MSCs in bone
605marrow [17]. ASCs cultured in vitro in the form of 3D
606spheroids have improved viability, self-renewal capacity,
Figure 5 Adipogenic
differentiation of spheroids
cultured in ADM after 7 days.
Visualization of cell
morphology (left picture) and
deposition of extracellular
structures (collagen III, right
picture). Black arrow: lipid
droplet. Transmission electron
microscopy
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Figure 6 a–d ASCs seeded on
GelMA: 20,000 ASCs were
seeded on GelMA films and
cultured in control or
adipogenic differentiation
medium. Oil Red O staining at
14 days taken with a
combination of Brightfield
and TxRed filters. e–h ASC
encapsulation in GelMA
10 w/v%, 106 ASCs mL−1.
Pictures taken at 14 days. All
pictures are live/dead assays
taken with GFP filters. White
arrow: lipid droplets
Figure 7 Bioprinted scaffolds measure 13 × 13 × 1 mm. Pictures of constructs taken after physical gelation at 4 °C for 30 min and illuminated under
UV light (365 nm) at 8 mW cm−2 for 15 min in immersion fluid
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607 and differentiation potential compared to 2D-cultured cells
608 as seen in our experiments. A number of studies have
609 demonstrated that 3D bioprinting ASC single cells is not
610 cytotoxic and preserves proliferative and adipogenic dif-
611 ferentiation capabilities of non-printed ASCs [34]. This is
612 confirmed in our research: both encapsulated and printed
613 ASC spheroids show excellent viability. ASCs seeded on or
614 encapsulated in GelMA show a polyhedral morphology
615 with multilocular microvacuoles within the cell cytoplasm,
616 which are morphological features associated with immature
617 adipocytes.
618 To demonstrate the successful differentiation and long-
619 term maintenance of the 3D human adipose stem cell
620 spheroids as functional adipocytes, we analyzed expression
621 of PPAR-γ, a key gene involved in adipogenesis, using RT-
622 qPCR. An upregulation of the adipogenic specific genes
623 was observed in spheroids encapsulated in GelMA and
624subsequently bioprinted. mRNA levels of FABP-4 were
625five times higher and PPAR-γ levels were twice as high
626compared to the 2D control sample. These findings are
627consistent with a recent experiment of Kim et al. [45] who
628encapsulated ASC spheroids in an alginate solution and
629subsequently bioprinted the mixture. They measured PPAR-
630γ levels 4.40-fold higher than control samples. Turner et al.
631[17] measured 2–5-fold PPAR-γ expression in ASC
632spheroids cultured in ADM compared to 2D monolayer
633cultures. In the adipogenic differentiation process, several
634parameters can enhance the differentiation: (1) the adipo-
635genic culture medium, (2) the cellular environment (2D cell
636monolayers vs 3D spheroids), (3) the hydrogel (cells or
637spheroids encapsulated in the hydrogel) and (4) the hydro-
638gel processing (encapsulation or bioprinting). In the present
639work, we have analyzed the adipogenic expression after
6407 days. At that time point, the adipogenic culture medium
Figure 8 Bioprinting ASCs or
spheroids encapsulated in
GelMA. ASCs (superior row) or
spheroids (inferior row)
encapsulated in GelMA cultured
in ADM. Pictures are live/dead
assays at day 1 and 7 post-
printing (Olympus IX 81). A
good viability was observed
after 1 and 7 days. A slight
decline in viability was observed
after 7 days in
encapsulated ASCs
Figure 9 Left: confocal images
taken with Nikon A1R inverted
confocal microscope and
projected in 1 focal plane using
(Fiji is just) Image J software.
Picture is taken 7 days post
printing. Right: giant cell cluster
7 days post-printing spheroids in
GelMA. Picture taken with
Nikon A1R inverted confocal
microscope
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641 still have the largest influence on the adipogenic differ-
642 entiation. The other parameters (spheroid formation,
643 hydrogel and bioprinting) will definitely have an impact on
644 adipogenic differentiation but this can only be notified at
645 other time points. We believe that adipogenic differentiation
646 will be enhanced in spheroids compared to 2D monolayers
647 at very early time points due to cell–cell interactions. At
648 later time points, it will be expected that the differentiation
649 in cellular spheroids can be more homogeneous. Impor-
650 tantly, current experiments have been performed with
651 GelMA as bioink. In the future, other bioinks with
652 improved impact on adipogenic differentiation will be
653 developed. These are the reasons why 3D bioprinting did
654 not have a huge impact on adipogenic differentiation,
655 nevertheless, the adipogenic differentiation did show a
656 small increase compared to cells cultured as 2D
657 monolayers.
658 We are able to conclude that ASCs lose their pro-
659 liferative capability as seen in our sphericity measurements:
660 decrease in diameter until an equilibrium is reached.
661 Spheroids gradually exhibit behaviors associated with AT
662 such as triglyceride accumulation and expression of adi-
663 pogenic genes and transcription factors. In addition, ASC
664 spheroids vastly outperformed 2D monolayer cultures
665 regarding CD36 and PPAR-γ-expression due to contact-
666 inhibited proliferation which serves as a cue for enhanced
667 adipogenic differentiation [17]. A clear trend in upregula-
668 tion of both FABP-4 and PPAR-γ is seen in all spheroid
669 conditions compared to positive control consisting of ASCs
670 cultured in adipogenic culture medium for 7 days in our
671 experiments. This indicates differentiation toward mature
672adipocytes in bioprinted constructs. We measured spheroid
673clusters of almost 600 μm, which is way more than the
674200 μm fabricated spheroids. The bioprinting needle has an
675internal diameter of 0.25 mm in order to obtain higher
676resolutions. This leads to the hypothesis that clusters were
677formed after printing through tissue fusion, indicating tissue
678formation. In addition, they showed reasonable viability
679upon live/dead staining. Autonomous self-assembly TE
680such as spheroids is based on embryological processes of
681tissue development [28]. Our experiments showed no sig-
682nificant difference in gene expression comparing the dif-
683ferent spheroid conditions, marking the negligible influence
684of bioprinting on differentiation capacity in addition to
685excellent viability.
686Live/dead assays of the bioprinted constructs show a
687mean viability of 79% ± 0078 after 7 days of culture (n=
68830). Until now, no other research group has bioprinted ASC
689spheroids in GelMA. Single ASCs have been encapsulated
690in multiple experiments and show viabilities in the same
691range [46]. Huber et al. [34] incorporated mature adipocytes
692in methacrylated gelatin for ATE and measured its
693mechanical properties. The authors mention storage moduli
694similar to native AT when small forces (0.05 N) are applied.
695Under higher loads (0.5 N), the storage modulus of native
696AT was significantly higher than methacrylated gelatin.
697Natural AT is organized in lobules containing adipocytes,
698surrounded by connective tissue. Hence the big difference
699in storage moduli between low and high loads. Evidence
700shows that mechanical properties of a scaffold can influence
701the differentiation of mesenchymal stem cells to a specific
702lineage [6]. ASCs tend to differentiate toward an adipogenic
Figure 10 Real-time quantitative polymerase chain reaction analysis of
the gene expression of adipogenic markers FABP-4 and PPAR-γ. 2D
negative control: ASCs cultured in SCM (2D−) (n= 1), 2D positive
control: ASCs cultured in ADM (2D+) (n= 1), Spheroids cultured in
microchips in ADM (Sphe) (n= 3), Spheroids encapsulated in GelMA
and cultured in ADM (GM Sphe) (n= 3) and spheroids encapsulated
in GelMA and subsequently bioprinted (Print Sphe) (n= 2). PPAR-γ
and FABP-4 mRNA was measured after 7 days of culture. Bar graphs
represent the logarithmic normalized fold expression relative to control
ASCs (2D−) on day 0. Values are the mean fold change & SEM of n
replicate experiments; *p > 0.05 with Mann–Whitney U test
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703 cell type when seeded onto a softer scaffold [47]. It is dif-
704 ficult to engineer a bioink that features the variable
705 mechanical properties of a tissue and the anatomical rela-
706 tions of the different cell types. A bioink is only a temporary
707 scaffold that will be replaced by self-made ECM after cells
708 undergo self-assembly and self-organization.
709 We only used a 10 w/v% hydrogel because of its
710 excellent bioprinting properties, which is consistent with the
711 work of Huber et al. [34], who concluded that non-cured
712 GM in solution is cytocompatible with mature adipocytes in
713 the tested range of 0.6–10 w/v%. In our protocol GelMA
714 was illuminated up to 15 min in order to prevent dissolution
715 at 37 °C post-printing. This is significantly more than the
716 curing times of up to 1 min by Gungor-Ozkerim et al. [48].
717 Still, we managed to have a mean viability of 79%. Irg is the
718 most commonly used photoinitiator but its peak absorption
719 point is not optimal to work with living cells. The excitation
720 peak is around 279 nm. When working with cells, higher
721 wavelengths (365–400 nm) are used because 279 nm would
722 likely cause DNA damage and protein damage. The
723 absorption peak of VA-086® is ~385 nm, which is in the
724 UV-A range and has been shown to have excellent bio-
725 compatibility properties [49]. However, when a certain
726 mechanical stiffness is needed, Irg provides a better stiff-
727 ness without damaging the cells too much in comparison
728 with VA-086®, where cell viability is affected greatly to
729 obtain similar mechanical strength [50]. Scaffolds with VA-
730 086® must be crosslinked twice as long as those with
731 Irgacure to obtain a similar stiffness. Unfortunately, there is
732 no working protocol to bioprint encapsulated spheroids with
733 VA-086®. 15 min of UV crosslinking was needed to achieve
734 stable constructs at 37 °C with a mean viability of 79%
735 7 days post-printing. The key limitation in photocrosslink-
736 ing techniques for creating tissues is that exposure to
737 harmful UV-light is needed and that photoinitiators may be
738 cytotoxic in their precursor or radical form [51]. To avoid
739 the use of UV-light, photoinitiators can be activated with
740 blue (visible) light at 405 nm. This is obviously not as
741 damaging to cell viability, but a co-initiator and co-
742 monomer are needed to produce enough radicals. This is
743 why we still prefer the use of the more toxic UV-induced
744 photoinitiators. UV is also known to have limited penetra-
745 tion depth which might affect the overall polymerization
746 efficiency for large constructs. Lin et al. [52] evaluated the
747 effect of UV exposure on endothelial colony-forming cells
748 and mesenchymal stem cells. They found that moderate UV
749 light in UV spectrum of 320–500 nm at an intensity of
750 7.5W cm−2 had >90% viability if exposed up to 200 s. We
751 believe that the high number of cells in our constructs and
752 the fact that spheroids are strong aggregations of differ-
753 entiated cells, neither presence of Irg nor the UV-irradiation
754 has a direct negative influence on the short-term viability of
755 encapsulated spheroids. Photo-polymerization can be
756incorporated during the printing process: after each
757deposition of a layer, the construct is irradiated, which
758potentially shortens total exposure time since only a small
759layer of unexposed material needs to be penetrated by UV-
760light. No significant difference was found in viability
761between spheroids encapsulated in GelMA (80% ± 0.086)
762and spheroids encapsulated in GelMA and subsequently
763bioprinted (79% ± 0.078) after 7 days of culture (p > 0.05
764and n= 30). This means that the extruding pressures of
7650.050MPa do not exhibit a negative influence on cell via-
766bility. Although gelatin provides a cell supportive envir-
767onment to bioinks, its properties to protect cells from stress
768from bioprinting are low. This could mean that the physical
769structure of a spheroid offers slight protection against
770harmful factors of the bioprinting process. A decrease of
77120% in viability in both the spheroids encapsulated in
772GelMA and bioprinted spheroids can be administered to the
773detrimental effects of crosslinking radicals and UV radia-
774tion. Zhao et al. [53] optimized nozzle temperature during
775bioprinting to improve cell viability. The authors reported
77690% survival of HeLa cells at 25 °C nozzle temperature
777whereas 50% survival has been reported at 10 °C. This is in
778accordance to our nozzle temperature and room temperature
779of 23 °C. At 23 °C the applied pressure is around
7800.050MPa.
781Building stable, large-volume AT by conventional
782tissue-engineering methods presents numerous challenges.
783Standard subcutaneous AT consists of differentiated adi-
784pocytes that make up only 90% of the total volume [54].
785The main challenge is the establishment of a vascular sys-
786tem throughout the entire engineered tissue for long term
787survival in vivo. In mature AT, a well-defined vascular
788system is present with every adipocyte surrounded by one
789or more capillaries: AT triggers blood vessel formation and
790ECs promote preadipocyte differentiation [55]. A vascular
791system is a necessary component for AT engineering (long-
792term functionality) but also notoriously difficult to incor-
793porate. Organ-on-chip technology is the closest we have
794come to achieve a functional unit but their integration into
795functional bioprinted constructs need more efforts to suc-
796ceed [56]. In a next step, HUVEC’s could be introduced in
797the 3D spheroids. Unfortunately, adipocytes and endothelial
798cells have disparate preferred culture conditions, requiring
799compromised solutions. Occhetta et al. [32] obtained good
800results co-culturing BM-MSCs with HUVEC. They note
801that BM-MSCs nor HUVECs cultured alone could form a
802surrounding ECM at comparable levels as the co-cultured
803constructs. Spheroid organization in vitro prior to implan-
804tation has been shown to improve in vivo angiogenesis [57].
805We measured diameters of 153 ± 9.18 μm on day 1 and
806101 ± 5.70 μm on day 13 of culture in ADM with a sig-
807nificant difference (p < 0.001) compared to spheroids cul-
808tured in SCM. Viability tends to be higher in ADM
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809 compared to control medium in our experiments. The cells
810 cultured in SCM expressed a pseudo-sphere shape due to
811 the form of the microchip. After manipulation of ASC
812 spheroids in SCM, a high tendency to disintegrate into
813 single cells was observed and thus they could not be used as
814 control for encapsulated spheroids. Our spheroids cultured
815 in ADM showed compaction over time. The decrease of
816 diameter and darker color of spheroids in our experiments
817 may be explained by the increased cell-cell contact from
818 neighboring cells in three-dimensional culture. We limited
819 our research to 200 μm spheroids since the diffusion limit of
820 oxygen is usually around 200 μm in vivo [58]. ASC
821 spheroids release more hypoxia-related factors such as
822 VEGF than ASCs grown in 2D culture [59]. Hypoxia could
823 be beneficial for primitive cells but detrimental to differ-
824 entiating cells such as ASC spheroids. Addition of angio-
825 genic growth factors and endothelial precursor cells may
826 address these issues, as investigated by De Moor et al. [39].
827 Generating blood vessels in artificial tissue deals with the
828 ability of ECs to organize into blood vessels autonomously
829 [60]. For in vitro TE, a rudimental interconnected tubular
830 system must be available instantly, which matures into a
831 genuine vascular structure for the fast integration of the
832 engineered tissue to the host tissue. It is expected that this
833 pre-structuring may guide the direction of growth into an
834 interconnected capillary system. Recently, complex 3D
835 tissue constructs containing parenchymal cells and vascular
836 cells have been implanted in experimental models [61].
837 These studies show that functional tissue organoids can be
838 constructed in vitro and implanted in tissue, with evidence
839 of vascular integration between implanted and recipient
840 circulations and restoration of tissue function by the
841 organoids.
842 5 Conclusion
843 Bioprinting AT results from the combination of an
844 increased need for breast reconstructions in today’s society
845 characterized by simplicity along with a low complication
846 profile. Bioprinting ASC spheroids could revolutionize soft
847 tissue reconstruction and counteract donor site morbidity,
848 lengthy operations and microsurgical expertise. We provide
849 a method to form nearly perfect round spheroids with
850 minimal variability to be bioprinted in a desired 3D con-
851 figuration. The ability to culture spheroids post-printing for
852 extended periods of time, up to 14 days with excellent
853 viability, has been achieved. Further research is needed to
854 integrate endothelial precursor cells in spheroids to fabricate
855 prevascularized constructs in vitro before implantation and
856 to stimulate adipogenesis. This proof-of-concept enables
857 researchers to further investigate suchQ4 possibilities.
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